SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-082251
Filing Date
2022-07-25
Accepted
2022-07-25 08:00:47
Documents
14
Period of Report
2022-07-21
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2221681d1_8k.htm   iXBRL 8-K 36364
2 EXHIBIT 3.1 tm2221681d1_ex3-1.htm EX-3.1 1410
3 GRAPHIC tm2221681d1_ex3-1img001.jpg GRAPHIC 248775
  Complete submission text file 0001104659-22-082251.txt   559366

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA syn-20220721.xsd EX-101.SCH 3060
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20220721_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20220721_pre.xml EX-101.PRE 22614
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2221681d1_8k_htm.xml XML 3728
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 221101265
SIC: 2834 Pharmaceutical Preparations